City Center Advisors LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
850
+38
+5% +$38.8K 0.83% 27
2026
Q1
$747K Buy
812
+12
+2% +$12.2K 0.69% 41
2025
Q4
$860K Sell
800
-16
-2% -$15.3K 0.79% 25
2025
Q3
$623K Sell
816
-34
-4% -$25.3K 0.61% 45
2025
Q2
$663K Buy
850
+25
+3% +$19.4K 0.71% 26
2025
Q1
$681K Buy
825
+260
+46% +$216K 0.8% 23
2024
Q4
$436K Buy
565
+29
+5% +$24K 0.49% 68
2024
Q3
$475K Buy
536
+1
+0.2% +$899 0.53% 58
2024
Q2
$416K Hold
535
0.49% 70
2024
Q1
$416K Buy
+535
New +$381K 0.49% 70

Other funds holding LLY

City Center Advisors LLC's LLY Position: Q2 2026 in Review

City Center Advisors LLC increased its Eli Lilly (LLY) stake by 4.7% in Q2 2026, buying an estimated $38.8K and bringing the position to 850 shares worth $1.02M. The position accounts for 0.83% of the portfolio, ranked #27.

City Center Advisors LLC first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • City Center Advisors LLC held 850 shares of Eli Lilly worth $1.02M as of Q2 2026.
  • City Center Advisors LLC bought 38 Eli Lilly shares in Q2 2026, an estimated $38.8K.
  • Eli Lilly made up 0.83% of City Center Advisors LLC's portfolio in Q2 2026, its #27 holding.
  • City Center Advisors LLC first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on City Center Advisors LLC's 13F filing for Q2 2026, filed 7 Jul 2026.